Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Occidental Petroleum
OXY
5
Louisiana-Pacific
LPX
CN Stock MarketDetailed Quotes
300725 PharmaBlock Sciences
- 31.77
- -0.64-1.97%
Market Closed May 9 15:00 CST
6.35BMarket Cap30.81P/E (TTM)
32.58High31.77Low35.40KlotVolume32.41Open32.41Pre Close113.19MTurnover2.10%Turnover Ratio28.91P/E (Static)199.73MShares45.8052wk High2.19P/B5.35BFloat Cap24.3852wk Low38.89Limit Up168.40MShs Float210.29Historical High25.93Limit Down2.50%Amplitude4.46Historical Low0.31Dividend TTM31.97Avg Price19.47KlotAsk0.98%Div YieldTTM100Lot Size14.15KlotBid
About PharmaBlock Sciences Company
The company is a supplier of innovative chemical products and services in the field of global pharmaceutical R&D and manufacturing. The company has always been committed to helping partners improve the efficiency of new drug discovery and development through innovation in chemistry and low-carbon technology in R&D and production processes, ensure stable product quality, continuously reduce R&D and production costs, and actively promote the green and sustainable development of the industry. The company's main business is the design, synthesis and sale of pharmaceutical molecular blocks; process development, pilot testing, commercial production and sales of key intermediates; and technical services related to the development and process production of pharmaceutical molecular blocks. The company's main products include molecular blocks, chemical R&D services, development and production services. The company's honors include Jiangsu Engineering Technology Research Center, Nanjing Engineering Technology Research Center, and Jiangsu High-tech Enterprise Certification.
Company Profile
Short Name-A药石科技
Symbol-A300725
Company NamePharmaBlock Sciences (Nanjing), Inc.
Listing DateNov 10, 2017
Issue Price11.32
Shares Offered18.33M share(s)
FoundedDec 26, 2006
Legal Representativeminmin yang
General Managerminmin yang
Secretaryshanbao yu
Accounting FirmNotarized Tianye Certified Public Accountants Firm (Special General Partnership)
Securities Representativejin lu
Legal CounselBeijing Guofeng Law Firm
Employees1325
Phone025-86918230
Office AddressNo. 81 Huasheng Road, Jiangbei New District, Nanjing
Zip Code210032
Registered AddressNo. 81 Huasheng Road, Jiangbei New District, Nanjing, Jiangsu
Fax025-86918262
Emailir@pharmablock.com
Websitehttp://www.pharmablock.com/
Business License320100400037244
BusinessTechnology development, technical consulting, technical services, technology transfer in the field of biomedicine expertise; R&D, production and sales of biomedical intermediates (excluding pharmaceuticals); import and export business of various commodities and technologies; industrial investment; investment services and consulting; investment management; R&D, production and sales of chemical preparations and chemical raw materials (operated under license), e-commerce technical services. Mechanical equipment research and development; mechanical equipment sales; special equipment repair; special equipment manufacturing (excluding licensed professional equipment manufacturing); industrial automatic control system device manufacturing; industrial automatic control system device sales; licensing projects: Class II value-added telecommunications business (projects subject to approval according to law, business activities can only be carried out after approval by relevant departments)
Company Executives
- Name
- Position
- Salary
- minmin yang
- Chairman, Directors, General Manager, Chairman of the Strategy and ESG Committee, Nomination Committee Members
- 1.42M
- juanjuan wu
- Directors, Audit Committee Member
- 550.00K
- yuanping jie
- Directors, Strategy and ESG Committee Member
- 780.00K
- chen chen
- Directors, Member of the Remuneration and Assessment Committee
- 350.00K
- xihe jiang
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 10.00K
- xiaonan zheng
- Independent Directors, Chairman of the Nomination Committee, Strategy and ESG Committee Member
- 10.00K
- li jin
- Independent Directors, Nomination Committee Members, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
- 120.00K
- shanbao yu
- Board Secretary
- 910.00K
- jin lu
- Securities Affairs Representative
- --
- shuqiang zhang
- Chairman of the Supervisory Board, Auditors
- 690.00K
- jin li
- Auditors
- 80.00K
- zhihong chen
- Executive Deputy General Manager
- --
- yifei wu
- Chief Financial Officer
- 1.04M
- jie cai
- Employee Supervisors
- 880.00K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting